PSI Sci
New here? Follow the money and the votes · Not sure of your district? Find your U.S. House member · Find your state legislators

H.R. 2871: Preserving Patient Access to Compounded Medications Act of 2017

Before you vote › Federal bills

H.R. 2871: Preserving Patient Access to Compounded Medications Act of 2017

115th Congress · introduced 2017-06-12 · Health · Latest: Referred to the Subcommittee on Health.

federal

Follow this bill, step by step

  1. Where it came from: introduced 2017-06-12 · official record
  2. Who proposed it: Rep. Griffith, H. Morgan [R-VA-9] · what a sponsor is
  3. What happened next: no floor votes in our records yet. Why?
  4. Where it stands now: Referred to the Subcommittee on Health. Not final yet: this can still change. We check for updates every day.
  5. If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.

What does this mean?

Official title

Preserving Patient Access to Compounded Medications Act of 2017

Plain summary

Preserving Patient Access to Compounded Medications Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to expand the circumstances under which a drug may be compounded (manufactured at small scale) to allow pharmacists and physicians to compound drugs for administration to patients in an office or clinical setting, in accordance with state law. (Drugs that are compounded do not need to meet certain federal requirements regarding manufacturing, labeling, or approval.) Dietary supplements may be used in the compounding of a drug. The bill exempts from interstate distribution limits the dispensing of a compounded drug from the facility where it is compounded to a patient or health facility. The scope of Food and Drug Administration (FDA) inspections of compounding pharmacies is limited to pertinent equipment, materials, containers, and labeling, which is the same scope as inspections of pharmacies. (Currently, the scope of inspections of compounding pharmacies is the same scope as inspections of drug manufacturers.) The bill eliminates the requirement for compounding pharmacies to register with the FDA as drug manufacturers.

Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.

What a vote does

A “Yea” vote

If it passes both chambers and is signed, it becomes law.

A “Nay” vote

If it is not passed, current law stays as it is.

PSI Sci description of the legislative step (not an opinion).

What does this mean? (plain words)

Official text

Preserving Patient Access to Compounded Medications Act of 2017

Source: Congressional Research Service summary (Introduced in House)

AI explanation – may be wrong, check the official text

No AI explanation yet. It takes up to a minute to write and is then saved for everyone.

Limited to a few requests an hour per person.

The strongest published arguments

Arguments for (supporters)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Arguments against (opponents)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. Griffith, H. Morgan [R-VA-9] · 62 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

Henry Cuellar (D-TX), Earl L. "Buddy" Carter (R-GA), Pete Sessions (R-TX), Andy Biggs (R-AZ), Paul A. Gosar (R-AZ), Neal P. Dunn (R-FL), Brian Babin (R-TX), Joyce Beatty (D-OH), Andy Barr (R-KY), Darin LaHood (R-IL), Scott DesJarlais (R-TN), Robert J. Wittman (R-VA), Kevin Cramer (R-ND), Roger Marshall (R-KS), Ken Calvert (R-CA), Gary J. Palmer (R-AL), Ted Budd (R-NC), Mark E. Amodei (R-NV), Clay Higgins (R-LA), Mike Johnson (R-LA), Donald Norcross (D-NJ), Barry Loudermilk (R-GA) and 2 more.

Sponsor's campaign money: Rep. Griffith, H. Morgan [R-VA-9] reported raising $2.2 million (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Words on this page, explained (1)
Bill
A proposed law. It becomes law only if it passes the legislature and is signed by the president or governor (or a veto is overridden).

Plain meanings written from linked sources. All words.

Sources

Record fed-us-cong115-hr2871 · catalog fed-us-congress-bills-cong115 · updated 2026-11-15 by psicol fed-bills-cong115